• A case report on congenital hypothyroidism and alpha thalassemia in children with anemia and muscle damage as the main manifestation
• A critical review of therapeutic interventions in sickle cell disease: Progress and challenges
• A high stable sample loading for analysis of adult alpha-thalassemia via the improved microarray isoelectric focusing of Hb species
• A multiplexed, allele-specific recombinase polymerase amplification assay with lateral flow readout for sickle cell disease detection
• A Review of Gene Therapies for Hemoglobinopathies
• Acute chest syndrome in sickle cell disease
• Addressing the Thalassemia Burden in Pakistan: The urgent need for a mandate on premarital screening
• Advances in Hemoglobinopathies and Thalassemia Evaluation
• Allogeneic Hematopoietic Stem Cell Transplantation-Induced Anaphylaxis in 2 Pediatric Cases
• Anemia and iron overload as prognostic markers of outcomes in β-thalassemia
• Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement
• Association between fetal hemoglobin, lactate dehydrogenase, and disease severity in patients with sickle cell disease at Bugando Medical Centre, Mwanza, Tanzania
• Beta-thalassemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassemia mutation
• Biophysical profiling of red blood cells from thin-film blood smears using deep learning
• Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease
• Case report-unveiling a case of hemoglobin D-Punjab variant with iron deficiency anemia in Sindh (Pakistan)
• Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant
• Cell and gene therapy accessibility
• Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients
• Clinical efficacy of thalidomide for various genotypes of beta thalassemia
• Clinical, aetiological and therapeutic features of severe sickle cell related vaso-occlusive crisis at the Sylvanus Olympio University Hospital, Lomé
• Counting Conditions on Newborn Bloodspot Screening Panels in Australia and New Zealand
• CRISPR/Cas12a-triggered ordered concatemeric DNA probes signal-on/off multifunctional analytical sensing system for ultrasensitive detection of thalassemia
• DAHEAN: A Danish nationwide study ensuring quality assurance through real-world data for suspected hereditary anemia patients
• DNA damage repair in megakaryopoiesis: molecular and clinical aspects
• Eliminating Health Care Access and Quality Inequities in Sickle Cell Disease: Policy Lessons from the End Sepsis Initiative
• Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics
• Emergency department management of patients with sickle cell disease
• Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease
• EPCR shedding light on sickle nephropathy
• Etiology and perinatal outcomes between early and late-onset nonimmune hydrops fetalis
• Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases
• Examining community-level social vulnerability and emergency department use for people living with sickle cell disease in Michigan
• Exciting science from the 16th International Conference on Thalassemia and Hemoglobinopathies
• Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives
• Exploring the genetic mechanisms: SELP gene's contribution to alleviating vaso-occlusive crisis in sickle cell disease
• From Alpha-Thalassemia Trait to <em>NPRL3</em>-Related Epilepsy: A Genomic Diagnostic Odyssey
• Gene therapies on the horizon for sickle cell disease: a clinician's perspective
• Genetic variants of dectin-1 and their antifungal immunity impact in hematologic malignancies: A comprehensive systematic review
• Genome editing in K562 cells suggests a functional role for the XmnI Gg polymorphism: a widely used genetic marker in β-thalassemia and sickle cell disease patients
• Genome-wide methylation and gene-expression analyses in thalassemia
• Glucose-6-phosphate dehydrogenase deficiency as a cause for nonimmune hydrops fetalis and severe fetal anemia: A systematic review
• Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report
• Hemoglobin Oviedo (<em>c.115A &gt; G; p.T39A</em>): A Cause of Low Oxygen Saturation
• Hydroxyurea achieved a hematologic response in a patient with β-thalassemia and secondary severe thrombocytosis post splenectomy
• Hydroxyurea in the sickle cell disease modern era
• In Utero Gene Therapy and its Application in Genetic Hearing Loss
• Influence of Hemoglobin Strasbourg, a Rare High Oxygen Affinity Hemoglobin Variant, on Different Methods of HbA1c Measurement
• Inhibitory Effects of Aspirin and Ibuprofen Overdose on Cholinesterase Activity: In Vivo and In Vitro Studies
• Introduction to a review series on globin disorders
• Iron metabolism in sickle cell disease patients undergoing chronic red blood cell exchange: A delicate homeostasis in balance
• Iron scavenging and myeloid cell polarization
• Luspatercept for non-deletional hemoglobin H disease
• Management of osteonecrosis of the humeral head in the pediatric population: A systematic review
• Measurement of left atrial size as a predictor of severity of illness in sickle cell disease
• Meta-Analytical and Meta-Regression Evaluation of Subclinical Hyperthyroidism's Effect on Male Reproductive Health: Hormonal and Seminal Perspectives
• Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients
• Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis
• Mutation Analysis of PAH Gene in Phenylketonuria Patients from the North of Iran: Identification of Three Novel Pathogenic Variants
• Nonimmune Hydrops Fetalis
• Noninvasive Prenatal Genetic Screening of Cell-Free Fetal DNA for Early Prediction of β-Thalassemia Using Fiber Optic Nanogold-Linked Sorbent Assay
• Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
• PGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease
• Post-GWAS Validation of Target Genes Associated with HbF and HbA₂ Levels
• Post-infectious Moyamoya Syndrome: A Review of Existing Scientific Literature From 2000 to 2023
• Prediction of Functional Academic Outcomes by Fine Motor Skills in Individuals With Sickle Cell Disease
• Presentation of Acute Pancreatitis in Sickle Cell Disease Patients: A Single Hospital Experience
• Prevalence and Regional Distribution of Beta-Hemoglobin Variants in Saudi Arabia: Insights from the National Premarital Screening Program"
• Prevalence, patterns, and factors associated with abnormal lung function among children with sickle cell disease in Uganda: a cross-sectional study
• Protective Effect of Zinc Oxide Nanoparticles on Bisphenol S-Induced Cytotoxicity in Human Embryonal Testicular Carcinoma Cell Line
• Providing the Tools to Facilitate Quality Care for Children with Sickle Cell Disease
• Radiofrequency Ablation (RFA) for Osteoid Osteoma in an 11-Year-Old Male Child With Sickle Cell Trait: A Case Report
• Recurrent haemorrhagic venous infarct in a patient with sickle cell disease
• Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
• Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses
• Safety and efficacy studies of CRISPR/Cas9 treatment of sickle cell disease in clinically relevant conditions highlights disease-specific responses
• Seroprevalence of SARS-CoV-2 in pediatric hematology-oncology patients
• Serum visfatin level in β-thalassemia and its correlation with disease severity
• Sexually transmitted infection testing and diagnosis in adolescents and young adults with sickle cell disease
• Sickle cell disease - common and dangerous complications
• Sickle cell disease in Indian tribal population: Findings of a multi-centre Indian SCD registry
• Splenectomy in Thalassemia: The Role of Surgery as an Adjunct to Medical Management
• Splenic complications in pediatric sickle cell disease: A retrospective cohort review
• Studies of Exagamglogene Autotemcel - Age and Place
• Studies of Exagamglogene Autotemcel - Age and Place. Reply
• SURGICAL OUTCOMES IN CONCURRENT SICKLE CELL AND DIABETIC RETINOPATHY
• SURGICAL OUTCOMES OF RETINAL DETACHMENT ASSOCIATED WITH PROLIFERATIVE SICKLE CELL RETINOPATHY
• Telomere Dynamics in Sickle Cell Anemia: Unraveling Molecular Aging and Disease Progression
• Thalassaemia: NICE recommends "life changing" gene editing therapy
• The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for α-Thalassemia-1 Chiang Rai (--^CR) Type Deletion with Hb Constant Spring
• The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran
• The molecular mechanism responsible for HbSC retinopathy may depend on the action of the angiogenesis-related genes <em>ROBO1</em> and <em>SLC38A5</em>
• The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals
• The Ugandan sickle Pan-African research consortium registry: design, development, and lessons
• Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in Tanzania
• Transcriptional Repressor BCL11A in Erythroid Cells
• Unpacking the utility of euvolemic automated transfusion in sickle cell disease
• Update on SickleInAfrica: a collaborative and multidimensional approach to conduct research and improve health
• Updates in Pediatric Sickle Cell Lung Disease
• What is the future of digital tools to help manage pain in sickle cell disease patients?